SIMCERE PHARMACEUTICAL GROUP Accounts Receivable, before Allowance for Credit Loss, Current
SIMCERE PHARMACEUTICAL GROUP had Accounts Receivable, before Allowance for Credit Loss, Current of CNY 390.60 million as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableGrossCurrent · last filed 2013-04-26
- 2012-12-31: Accounts Receivable, before Allowance for Credit Loss, Current 390.60M CNY.
- 2011-12-31: Accounts Receivable, before Allowance for Credit Loss, Current 469.34M CNY.
CNY
| Period end | Accounts Receivable, before Allowance for Credit Loss, Current |
|---|---|
| 2012-12-31 | 390.60M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 469.34M CNY 20-F · filed 2013-04-26 |
USD
| Period end | Accounts Receivable, before Allowance for Credit Loss, Current |
|---|---|
| 2012-12-31 | $62.70M 20-F · filed 2013-04-26 |